Meyka Pro banner
Celcuity Inc.

Celcuity Inc. (CELC) Stock Overview

Explore Celcuity Inc.’s financial performance, market position, analyst ratings, and future outlook.

CELCNASDAQ
HealthcareBiotechnology
$82.78
$0.75(0.90%)
U.S. Market is Open · 13:34

Celcuity Inc. (CELC)

Meyka AI Score

Z

Key Financials

Market Cap4B
P/E Ratio-19.07
EPS (TTM)$-4.30
ROE-3.51%
Fundamental Analysis

AI Price Forecasts

1 Month$89.31
3 Months$178.52
1 Year Target$150.31

CELC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Celcuity Inc. (NASDAQ: CELC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Celcuity Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CELC on the NASDAQ shows an RSI of 36.70, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $150.31 for the NASDAQ listing.

Key metrics behind Celcuity Inc.'s NASDAQ-traded stock include a P/E ratio of -19.07 and a market capitalization of 4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CELC on the NASDAQ.

Price Performance (NASDAQ: CELC)

1-Day Change
-0.99%
5-Day Change
-6.42%
1-Month Change
-10.11%
3-Month Change
-6.28%
6-Month Change
-27.60%
Year-to-Date (YTD) Change
-17.08%
1-Year Change
50.17%
3-Year Change
694.43%
5-Year Change
306.59%
All-Time (Max) Change
478.73%

Contact Information

763 392 0767
2800 Campus Drive, Minneapolis, MN, 55441

Company Facts

1,550 Employees
IPO DateSep 19, 2017
CountryUS
Actively Trading

Frequently Asked Questions